GM-CSF was also pathogenic in experimental models of SpA (45) and is emerging as a central player in chronic inflammatory diseases, including mouse models of multiple sclerosis (46), bowel inflammation (47), and RA (48). The gene discussed is CSF2; the disease is multiple sclerosis.